JP2013525440A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013525440A5 JP2013525440A5 JP2013508147A JP2013508147A JP2013525440A5 JP 2013525440 A5 JP2013525440 A5 JP 2013525440A5 JP 2013508147 A JP2013508147 A JP 2013508147A JP 2013508147 A JP2013508147 A JP 2013508147A JP 2013525440 A5 JP2013525440 A5 JP 2013525440A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- effective amount
- therapeutically effective
- day
- balsalazide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- IPOKCKJONYRRHP-FMQUCBEESA-N balsalazide Chemical compound C1=CC(C(=O)NCCC(=O)O)=CC=C1\N=N\C1=CC=C(O)C(C(O)=O)=C1 IPOKCKJONYRRHP-FMQUCBEESA-N 0.000 claims description 29
- 229960004168 balsalazide Drugs 0.000 claims description 29
- 239000003826 tablet Substances 0.000 claims description 24
- 239000002775 capsule Substances 0.000 claims description 16
- 206010009900 Colitis ulcerative Diseases 0.000 claims description 12
- 201000006704 Ulcerative Colitis Diseases 0.000 claims description 12
- 238000009472 formulation Methods 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 12
- 239000007941 film coated tablet Substances 0.000 claims description 8
- 230000035876 healing Effects 0.000 claims description 5
- 230000001939 inductive effect Effects 0.000 claims description 5
- 208000018522 Gastrointestinal disease Diseases 0.000 claims description 4
- 206010038063 Rectal haemorrhage Diseases 0.000 claims description 4
- 208000010643 digestive system disease Diseases 0.000 claims description 3
- 230000037406 food intake Effects 0.000 claims description 3
- 235000012631 food intake Nutrition 0.000 claims description 3
- 208000018685 gastrointestinal system disease Diseases 0.000 claims description 3
- 230000013872 defecation Effects 0.000 claims description 2
- 238000001839 endoscopy Methods 0.000 claims description 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 35
- 238000002579 sigmoidoscopy Methods 0.000 claims 1
- 238000000034 method Methods 0.000 description 35
- 238000002052 colonoscopy Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32815110P | 2010-04-26 | 2010-04-26 | |
| US61/328,151 | 2010-04-26 | ||
| PCT/US2011/033905 WO2011137103A1 (en) | 2010-04-26 | 2011-04-26 | Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives for the treatment of males |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013525440A JP2013525440A (ja) | 2013-06-20 |
| JP2013525440A5 true JP2013525440A5 (enExample) | 2014-06-19 |
Family
ID=44861888
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013508147A Pending JP2013525440A (ja) | 2010-04-26 | 2011-04-26 | 男性の治療のための２−ヒドロキシ−５−フェニルアゾ安息香酸誘導体の製剤および使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US8497256B2 (enExample) |
| EP (1) | EP2563117B1 (enExample) |
| JP (1) | JP2013525440A (enExample) |
| AU (1) | AU2011245455A1 (enExample) |
| BR (2) | BR112012027520A2 (enExample) |
| CA (1) | CA2797560A1 (enExample) |
| IL (1) | IL222642A0 (enExample) |
| MX (1) | MX358142B (enExample) |
| WO (1) | WO2011137103A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2021528385A (ja) * | 2018-06-05 | 2021-10-21 | フラッグシップ パイオニアリング イノベーションズ ブイ， インコーポレイテッド | 自己免疫障害を治療するためのアシル化活性剤およびその使用方法 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US326364A (en) | 1885-09-15 | Electric-lamp hanger | ||
| US4298595A (en) | 1978-12-20 | 1981-11-03 | Dynapol | Pharmaceutical preparations containing a polymeric agent for releasing 5-aminosalicylic acid or its salts into the gastrointestinal tract |
| DE3887353T2 (de) | 1987-10-12 | 1994-05-05 | Capability Services Pty Ltd | Behandlungsverfahren für magen-darm-krankheiten. |
| US5443826A (en) | 1988-08-02 | 1995-08-22 | Borody; Thomas J. | Treatment of gastro-intestinal disorders with a fecal composition or a composition of bacteroides and E. Coli |
| US5519014A (en) | 1990-10-22 | 1996-05-21 | Borody; Thomas J. | Treatment of non-inflammatory and non-infectious bowel disorders |
| US5498608A (en) | 1994-01-07 | 1996-03-12 | Salix Pharmaceuticals | Use of 2-hydroxy-5-phenylazobenzoic acid derivatives as colon cancer chemopreventative and chemotherapeutic agents |
| US5905073A (en) | 1995-01-06 | 1999-05-18 | Salix Pharmaceuticals, Inc. | Use of 2-hydroxy-5-phenylazobenzoic acid derivatives as colon cancer chemopreventative and chemotherapeutic agents |
| SE9700934D0 (sv) | 1997-03-14 | 1997-03-14 | Astra Ab | New formulation |
| US6277836B1 (en) | 1997-04-01 | 2001-08-21 | Thomas Julius Borody | Methods and compositions for treating inflammatory bowel disease |
| US6551632B2 (en) | 1997-04-01 | 2003-04-22 | Thomas Julius Borody | Methods and compositions for treating inflammatory bowel disease |
| AUPO665397A0 (en) | 1997-05-07 | 1997-05-29 | Borody, Thomas Julius | Novel therapy for constipation |
| AUPP437698A0 (en) | 1998-06-30 | 1998-07-23 | Baumgart, Karl | Methods for treatment of coronary, carotid and other vascular disease |
| US6326364B1 (en) | 1999-02-08 | 2001-12-04 | Cedars-Sinai Medical Center | Use of 5-aminosalicylates as antimicrobial agents |
| CN101247812A (zh) | 2005-08-24 | 2008-08-20 | 萨利克斯药品公司 | 巴柳氮制剂及其生产和应用 |
| US8921344B2 (en) * | 2006-11-03 | 2014-12-30 | Salix Pharmaceuticals, Inc. | Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives |
| US7452872B2 (en) * | 2005-08-24 | 2008-11-18 | Salix Pharmaceuticals, Inc. | Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives |
| CA2662430A1 (en) | 2006-09-13 | 2008-03-20 | The Procter & Gamble Company | Methods of treatment for ulcerative colitis using aminosalicylate |
-
2011
- 2011-04-26 US US13/094,261 patent/US8497256B2/en active Active
- 2011-04-26 CA CA2797560A patent/CA2797560A1/en not_active Withdrawn
- 2011-04-26 EP EP11775497.8A patent/EP2563117B1/en active Active
- 2011-04-26 MX MX2012012324A patent/MX358142B/es active IP Right Grant
- 2011-04-26 WO PCT/US2011/033905 patent/WO2011137103A1/en not_active Ceased
- 2011-04-26 BR BR112012027520A patent/BR112012027520A2/pt not_active IP Right Cessation
- 2011-04-26 JP JP2013508147A patent/JP2013525440A/ja active Pending
- 2011-04-26 AU AU2011245455A patent/AU2011245455A1/en not_active Abandoned
- 2011-04-26 BR BR122014009845A patent/BR122014009845A2/pt not_active Application Discontinuation
-
2012
- 2012-10-23 IL IL222642A patent/IL222642A0/en unknown
-
2013
- 2013-07-10 US US13/938,777 patent/US20130295178A1/en not_active Abandoned
-
2014
- 2014-10-08 US US14/509,446 patent/US20150132381A1/en not_active Abandoned